Skye Bioscience, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2024-03-27: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2024-03-13; Total offering amount $40,000,000.
- 2017-11-14: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2017-11-01; Total offering amount $2,000,000.
- 2017-01-13: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2017-01-03; Total offering amount $1,500,000.
- 2016-11-03: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2016-10-26; Total offering amount $500,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2024-03-27 | Rule 506(b) | Equity | 2024-03-13 | $40,000,000 | $40,000,000 | $0 | 13 |
| 2017-11-14 | Rule 506(b) | Equity | 2017-11-01 | $2,000,000 | $2,000,000 | $0 | 2 |
| 2017-01-13 | Rule 506(b) | Equity | 2017-01-03 | $1,500,000 | $1,200,000 | $300,000 | 5 |
| 2016-11-03 | Rule 506(b) | Equity | 2016-10-26 | $500,000 | $500,000 | $0 | 1 |
| 2015-01-09 | Rule 506(b) | Equity | 2015-01-07 | $724,989 | $724,989 | $0 | 7 |
| 2014-11-13 | Rule 506(b) | Equity | 2014-10-31 | Indefinite | $0 | Indefinite | 43 |
| 2013-01-22 D/A | Rule 504 | Equity | 2012-11-08 | $24,800 | $24,800 | $0 | 13 |
| 2012-11-08 | Rule 504 | Equity | Yet to occur | Indefinite | $0 | Indefinite | 0 |
| 2012-11-07 D/A | Rule 504 | Equity | 2011-03-25 | $9,000 | $9,000 | $0 | 7 |
| 2011-03-25 | Rule 504 | Equity | Yet to occur | Indefinite | $0 | Indefinite | 0 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |